history of glp-1 Addressing patient concerns about the 'newness' and long-term safety GLP- 1 receptor agonists: A clinician's guide to counseling Frontiers | GLP-1R in diabetes

No, a pre-diabetic individual should not routinely take both metformin and a GLP-1 receptor agonist together, as current guidelines recommend against using G...

The Mark Cuban Cost Plus Drug Company seeks to provide commonly used medications at low prices by cutting out the middlemen.

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this strategy may not be effective for everyone.

Numerous analysts have said the GLP-1s are very likely to disrupt certain areas of the MedTech industry, while others say MedTech can live side-by-side with the weight-loss drugs.1 In fact, the impact of GLP-1s is likely to be more nuanced than the blunt conclusions drawn by market watchers, with some companies and segments affected more than others

Serena injecting herself to promote weight loss drug